Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [896]

Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck...

Prof Anthony Cmelak - Vanderbilt-Ingram Cancer Center, Nashville, USA

Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers ( Prof Anthony Cmelak - Vanderbilt-Ingram Cancer Center, Nashville, USA )

ASCO 2014 roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Lapatinib not found to be beneficial in head and neck cancer with high risk of...

Prof Kevin Harrington - Institute of Cancer Research, London, UK

Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence ( Prof Kevin Harrington - Institute of Cancer Research, London, UK )

Addition of docetaxel to initial hormone therapy substantially improves...

Dr Michael Carducci - Johns Hopkins School of Medicine, Baltimore, USA

Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer ( Dr Michael Carducci - Johns Hopkins School of Medicine, Baltimore, USA )

T-VEC injections into melanoma lesions show significant response rate

Prof Kevin Harrington - Institute of Cancer Research, London, UK

T-VEC injections into melanoma lesions show significant response rate ( Prof Kevin Harrington - Institute of Cancer Research, London, UK )

Impact of cytotoxics on pregnancy needs to be better understood

Dr Shahid Gilani - University Hospital of North Staffordshire, Stoke-on-Trent...

Impact of cytotoxics on pregnancy needs to be better understood ( Dr Shahid Gilani - University Hospital of North Staffordshire, Stoke-on-Trent, UK )

Genomic sequencing helps identify best candidates for adjuvant chemo in...

Dr Ramon Salazar - L'Hospitalet de Llobregat, Barcelona, Spain

Genomic sequencing helps identify best candidates for adjuvant chemo in colorectal cancer ( Dr Ramon Salazar - L'Hospitalet de Llobregat, Barcelona, Spain )

Addition of docetaxel to initial hormone therapy substantially improves...

Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA

Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )

First-line bevacizumab plus chemo and cetuximab plus chemo provide similar...

Dr Alan Venook; Prof Gordon McVie

First-line bevacizumab plus chemo and cetuximab plus chemo provide similar survival benefits in metastatic colorectal cancer ( Dr Alan Venook; Prof Gordon McVie )

ASCO 2014: Advances in prostate cancer discussion

Prof Noel Clarke; Dr Cora Sternberg; Dr Kurt Miller, Prof Wysocki

ASCO 2014: Advances in prostate cancer discussion ( Prof Noel Clarke; Dr Cora Sternberg; Dr Kurt Miller, Prof Wysocki )

First-line bevacizumab plus chemotherapy and cetuximab plus chemotherapy...

Dr Alan Venook - UCSF, San Francisco, USA

First-line bevacizumab plus chemotherapy and cetuximab plus chemotherapy provide similar survival benefit for patients with metastatic colorectal cancer ( Dr Alan Venook - UCSF, San Francisco, USA )

Addition of docetaxel to initial hormone therapy substantially improves...

Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA

Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer